New developments in hepatitis A control.
An inactivated vaccine for hepatitis A was recently licensed in Canada. This is the first important development in control of the disease in 50 years. This article presents new information about the vaccine and about the groups who might benefit from it. It also provides a review of the clinical and epidemiological aspects of hepatitis A.
Yuan
L
L
Department of Preventive Medicine and Biostatistics, University of Toronto.
D002170:Canada / Q000453:epidemiology; D004196:Disease Outbreaks; D006506:Hepatitis A / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control*; D017957:Hepatitis A Virus, Human / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins; D014481:United States / Q000453:epidemiology; D014765:Viral Vaccines / Q000008:administration & dosage
D007136:Immunoglobulins; D014765:Viral Vaccines